ENDRA Life Sciences Statistics
Total Valuation
NDRA has a market cap or net worth of $9.07 million. The enterprise value is $7.76 million.
| Market Cap | 9.07M |
| Enterprise Value | 7.76M |
Important Dates
The last earnings date was Monday, August 17, 2026, before market open.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NDRA has 1.50 million shares outstanding. The number of shares has increased by 113.32% in one year.
| Current Share Class | 1.50M |
| Shares Outstanding | 1.50M |
| Shares Change (YoY) | +113.32% |
| Shares Change (QoQ) | +106.34% |
| Owned by Insiders (%) | 4.73% |
| Owned by Institutions (%) | 10.24% |
| Float | 1.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.10, with a Debt / Equity ratio of 0.07.
| Current Ratio | 7.10 |
| Quick Ratio | 2.21 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -152.04% and return on invested capital (ROIC) is -94.78%.
| Return on Equity (ROE) | -152.04% |
| Return on Assets (ROA) | -77.32% |
| Return on Invested Capital (ROIC) | -94.78% |
| Return on Capital Employed (ROCE) | -92.93% |
| Weighted Average Cost of Capital (WACC) | 3.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$537,878 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.81% in the last 52 weeks. The beta is -0.04, so NDRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +37.81% |
| 50-Day Moving Average | 4.94 |
| 200-Day Moving Average | 4.76 |
| Relative Strength Index (RSI) | 62.98 |
| Average Volume (20 Days) | 41,701 |
Short Selling Information
The latest short interest is 30,078, so 2.01% of the outstanding shares have been sold short.
| Short Interest | 30,078 |
| Short Previous Month | 32,947 |
| Short % of Shares Out | 2.01% |
| Short % of Float | 2.10% |
| Short Ratio (days to cover) | 1.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.65M |
| Pretax Income | -5.92M |
| Net Income | -5.92M |
| EBITDA | -6.61M |
| EBIT | -6.65M |
| Earnings Per Share (EPS) | -$5.38 |
Balance Sheet
The company has $1.74 million in cash and $429,274 in debt, with a net cash position of $1.31 million or $0.87 per share.
| Cash & Cash Equivalents | 1.74M |
| Total Debt | 429,274 |
| Net Cash | 1.31M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 6.31M |
| Book Value Per Share | 4.21 |
| Working Capital | 4.80M |
Cash Flow
In the last 12 months, operating cash flow was -$4.82 million and capital expenditures -$18,670, giving a free cash flow of -$4.84 million.
| Operating Cash Flow | -4.82M |
| Capital Expenditures | -18,670 |
| Depreciation & Amortization | 38,551 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.84M |
| FCF Per Share | -$3.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NDRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -113.32% |
| Shareholder Yield | -113.32% |
| Earnings Yield | -65.20% |
| FCF Yield | -53.36% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Nov 7, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |